EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 2

Ensembl ID : ENSCCRG00000078513
Gene Symbol: GRIK2
1 Cross references
195 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSCCRG00000064017
Gene Symbol: GRIA1A
1 Cross references
248 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSCCRG00000035631
Gene Symbol: GRIA1A
1 Cross references
248 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1b

Ensembl ID : ENSCCRG00000033197
Gene Symbol: GRIA1B
1 Cross references
246 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1b

Ensembl ID : ENSCCRG00000013226
Gene Symbol: GRIA1B
1 Cross references
247 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2a

Ensembl ID : ENSCCRG00000022287
Gene Symbol: GRIA2A
1 Cross references
240 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2a

Ensembl ID : ENSCCRG00000020037
Gene Symbol: GRIA2A
1 Cross references
240 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSCCRG00000062450
Gene Symbol: GRIA2B
1 Cross references
254 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSCCRG00000067734
Gene Symbol: GRIA2B
1 Cross references
253 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 3b

Ensembl ID : ENSCCRG00000012151
Gene Symbol: GRIA3B
1 Cross references
196 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 3b

Ensembl ID : ENSCCRG00000012134
Gene Symbol: GRIA3B
1 Cross references
195 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSCCRG00000067130
Gene Symbol: GRIA4B
1 Cross references
249 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).